Difference between injection plain ropivacaine with injection ropivacaine and injection tramadol under spinal anaesthesia in patients for vaginal hysterectomy
Phase 4
- Conditions
- Health Condition 1: N998- Other intraoperative and postprocedural complications and disorders of genitourinary system
- Registration Number
- CTRI/2023/11/059932
- Lead Sponsor
- Dr Alieshia Siangshai
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. ASA 1 and 2 female patients.
2. Patients aged between 40 to 60 years.
3. Patients undergoing vaginal hysterectomy under spinal anaesthesia.
Exclusion Criteria
1. Patient refusal.
2. Patient history of allergy to opioids or local anaesthetic.
3. Patient with bleeding tendencies(due to either primary disease or use of anticoagulant)
4. Patient with neurological disorder.
5. Patient with spine abnormalities.
6. Morbidly obese patients.
7. Local site infection.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To assess the duration analgesia using Ropivacaine (0.75%) and Ropivacaine (0.75%) with Tramadol 25mg in spinal anaesthesia in patient udergoing vaginal hysterectomy.Timepoint: To study the duration analgesia at 0 min,30 mins,1,2,4,6,8,16,24 hours in the post operative period .
- Secondary Outcome Measures
Name Time Method 1. To evaluate the time of onset of sensory and motor blockade. <br/ ><br>2. Time of regression of segments of sensory blockade. <br/ ><br>3. Time of regression of motor blockade. <br/ ><br>4. Hemodynamic response. <br/ ><br>5. Adverse effects. <br/ ><br>6. Number of doses of recue analgesia required and time for first analgesic request.Timepoint: First24hours monitoring.